Summary of the practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults
- PMID: 11699811
- DOI: 10.1097/00004583-200111000-00020
Summary of the practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults
Abstract
This practice parameter describes treatment with stimulant medication. It uses an evidence-based medicine approach derived from a detailed literature review and expert consultation. Stimulant medications in clinical use include methylphenidate, dextroamphetamine, mixed salts of amphetamine, and pemoline. They carry U.S. Food and Drug Administration indications for the treatment of attention-deficit hyperactivity disorder.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical